Vir Biotechnology, Inc. (VIR) — Financial statements
Income statement, balance sheet, and cash flow for Vir Biotechnology, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 69↓7.6% | 74↓13.9% | 86↓94.7% | 1,616↑47.5% | 1,095 | |
| Cost of Revenue | 12↓97.6% | 479↓16.4% | 573↓7.8% | 621↑20.8% | 514 | |
| Gross Profit | 57↑114.1% | -404↑16.9% | -487↓148.9% | 995↑71.1% | 582 | |
| Operating Expenses | ||||||
| R&D Expenses | 433↓14.6% | 506↓12.6% | 580↑22.1% | 475↑5.9% | 448 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 92 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Expenses | 0.00↑100.0% | -324↑15.3% | -382↓22.1% | -313↓8.9% | -287 | |
| Operating Expenses | 525↑187.2% | 183↓7.6% | 198↑22.2% | 162↑0.6% | 161 | |
| Total Costs & Expenses | 537↓18.9% | 661↓14.2% | 770↓1.6% | 783↑16.0% | 675 | |
| Operating Results | ||||||
| Operating Income | -468↑20.3% | -587↑14.2% | -684↓182.1% | 833↑98.0% | 421 | |
| Depreciation & Amortization | 12↓19.8% | 15↓25.2% | 19↑186.8% | 7↑16.7% | 6 | |
| EBITDA | -426↑16.3% | -509↑20.7% | -642↓176.4% | 840↑96.9% | 427 | |
| EBIT | -438↑16.4% | -523↑20.8% | -661↓179.4% | 833↑98.0% | 421 | |
| Interest & Other Income | ||||||
| Net Interest Income | 40↓44.0% | 72↓17.5% | 87↑209.7% | 28↑6299.1% | 0.44 | |
| Interest Income | 40↓44.0% | 72↓17.5% | 87↑209.7% | 28↑6299.1% | 0.44 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | -30↑52.5% | -64↓174.3% | -23 | 0.00 | 0.00 | |
| Other Income / Expenses | 30↓52.8% | 64↑14.2% | 56↑171.2% | -79↓161.1% | 129 | |
| Income Before Tax | -438↑16.3% | -523↑16.7% | -628↓183.3% | 754↑37.2% | 550 | |
| Income Tax Expense | 0.22↑119.0% | -1↑91.2% | -13↓105.5% | 238↑1023.8% | 21 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -438↑16.1% | -522↑15.1% | -615↓219.2% | 516↓2.4% | 529 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -438↑16.1% | -522↑15.1% | -615↓219.2% | 516↓2.4% | 529 | |
| Bottom-Line Net Income | -438↑16.1% | -522↑15.1% | -615↓219.2% | 516↓2.4% | 529 | |
| EPS (Basic) | -3.16↑17.5% | -3.83↑16.6% | -4.59↓218.0% | 3.89↓4.4% | 4.07 | |
| EPS (Diluted) | -3.16↑17.5% | -3.83↑16.6% | -4.59↓219.8% | 3.83↓3.3% | 3.96 | |
| Weighted Average Shares | 139↑1.7% | 136↑1.6% | 134↑1.1% | 133↑2.1% | 130 | |
| Weighted Average Diluted Shares | 139↑1.7% | 136↑1.6% | 134↓0.5% | 135↑1.0% | 133 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.